Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

Keyera released both its fourth-quarter and full-year 2024 results. After digesting the news, we maintain our CAD 41 fair value estimate.

Q4 2024 Earnings Call Transcript February 12, 2025 Rapid7, Inc. misses on earnings expectations. Reported EPS is $0.48 EPS, ...

Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.

A real estate firm predicts that Orlando's rents could spike by the end of the year due to high demand and limited supply.

The commencement of gas supply from Turkmenistan to Türkiye on March 1 is expected to enhance Türkiye's energy security and ...

CSL’s balance sheet is in sound condition. Financial risk is low given low revenue cyclicality and product demand is being largely driven by chronic indications. We forecast CSL’s net debt to EBITDA ...

MOSCOW. Feb 7 (Interfax) - An International Monetary Fund (IMF) mission tasked with the seventh review of the Extended Fund Facility (EFF) arrangement will start working in Kiev on February 20, 2025, ...

Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Acadian Asset Management Incorporated Earnings Conference Call and Webcast for the Fourth Quarter 2024.

A News Desk Report Modernisation of the Tema Oil Refinery (TOR), development of a national pipeline network and reassessment of taxation policies that contribute to high fuel costs are the top issues ...

The head of CPP Investments’ energy portfolio speaks on investing in renewable and traditional energy as part of the energy ...

St. Paul Community Baptist Church, and other churches located in the East New York neighborhood of Brooklyn, are joining ...